Delivery Order SPE2DR25D3014-SPE2DR26FP1UZ
- Not listed
- The Defense Logistics Agency awarded a $9,831.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens on January 20, 2026, with completion targeted for January 21, 2026. This non-set-aside delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which does business as AmerisourceBergen), is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $35,035.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside contract is scheduled for completion by January 12, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. The delivery order is...
- The Defense Logistics Agency awarded a $22,247.52 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector medication on January 15, 2026, with completion scheduled for January 16, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $30,931.68 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of January 23, 2026. This firm fixed-price contract, awarded on January 22, 2026, represents a non-set-aside competitive award supporting federal medical procurement. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- The Defense Logistics Agency awarded a $13,410.70 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $14,440.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of January 13, 2026. This competitively awarded contract, issued January 12, 2026, carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing...
- The Defense Logistics Agency awarded a $20,649.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 23, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical product, with an ultimate completion date of January 26, 2026. This non-set-aside competitive award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.48 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a subsidiary of...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1UZDelivery Order
The Defense Logistics Agency awarded a $2,121.30 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on February 4, 2026, with completion expected by February 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. This delivery order is executed under Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 31, 2031), which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally. Repatha is a specialty cardiovascular medication used for cholesterol management, consistent with the IDC's broad portfolio covering prescription medications across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/3/26 |